Jovalekic, A.; Bullich, S.; Roé-Vellvé, N.; Kolinger, G.D.; Howard, L.R.; Elsholz, F.; Lagos-Quintana, M.; Blanco-Rodriguez, B.; Pérez-MartÃnez, E.; Gismondi, R.;
et al. Experiences from Clinical Research and Routine Use of Florbetaben Amyloid PET—A Decade of Post-Authorization Insights. Pharmaceuticals 2024, 17, 1648.
https://doi.org/10.3390/ph17121648
AMA Style
Jovalekic A, Bullich S, Roé-Vellvé N, Kolinger GD, Howard LR, Elsholz F, Lagos-Quintana M, Blanco-Rodriguez B, Pérez-MartÃnez E, Gismondi R,
et al. Experiences from Clinical Research and Routine Use of Florbetaben Amyloid PET—A Decade of Post-Authorization Insights. Pharmaceuticals. 2024; 17(12):1648.
https://doi.org/10.3390/ph17121648
Chicago/Turabian Style
Jovalekic, Aleksandar, Santiago Bullich, Núria Roé-Vellvé, Guilherme Domingues Kolinger, Lorelei R. Howard, Floriana Elsholz, Mariana Lagos-Quintana, Beatriz Blanco-Rodriguez, Esther Pérez-MartÃnez, Rossella Gismondi,
and et al. 2024. "Experiences from Clinical Research and Routine Use of Florbetaben Amyloid PET—A Decade of Post-Authorization Insights" Pharmaceuticals 17, no. 12: 1648.
https://doi.org/10.3390/ph17121648
APA Style
Jovalekic, A., Bullich, S., Roé-Vellvé, N., Kolinger, G. D., Howard, L. R., Elsholz, F., Lagos-Quintana, M., Blanco-Rodriguez, B., Pérez-MartÃnez, E., Gismondi, R., Perrotin, A., Chapleau, M., Keegan, R., Mueller, A., Stephens, A. W., & Koglin, N.
(2024). Experiences from Clinical Research and Routine Use of Florbetaben Amyloid PET—A Decade of Post-Authorization Insights. Pharmaceuticals, 17(12), 1648.
https://doi.org/10.3390/ph17121648
